These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26076870)
21. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study. Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664 [TBL] [Abstract][Full Text] [Related]
22. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients. Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227 [TBL] [Abstract][Full Text] [Related]
23. The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia. Demir B; Demir S; Pasa S; Guven S; Atamer Y; Atamer A; Kocyigit Y J Obstet Gynaecol; 2012 Aug; 32(6):525-8. PubMed ID: 22779953 [TBL] [Abstract][Full Text] [Related]
24. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198 [TBL] [Abstract][Full Text] [Related]
25. Correlation between blood asymmetric dimethylarginine level and the complications of patients with cardiovascular diseases. Wang D; Lai LH; Yan P; Dong PS J Biol Regul Homeost Agents; 2017; 31(1):133-139. PubMed ID: 28337882 [TBL] [Abstract][Full Text] [Related]
26. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow. Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626 [TBL] [Abstract][Full Text] [Related]
27. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638 [TBL] [Abstract][Full Text] [Related]
28. Biomarkers of the L-Arginine/Dimethylarginine/Nitric Oxide Pathway in People with Chronic Airflow Obstruction and Obstructive Sleep Apnoea. Hannemann J; Thorarinnsdottir EH; Amaral AFS; Schwedhelm E; Schmidt-Hutten L; Stang H; Benediktsdottir B; Gunnarsdóttir I; Gislason T; Böger R J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629272 [TBL] [Abstract][Full Text] [Related]
29. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats. Hsu CN; Huang LT; Lau YT; Lin CY; Tain YL Transl Res; 2012 Feb; 159(2):90-8. PubMed ID: 22243793 [TBL] [Abstract][Full Text] [Related]
30. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. Uzar E; Evliyaoglu O; Toprak G; Acar A; Yucel Y; Calisir T; Cevik MU; Tasdemir N J Headache Pain; 2011 Apr; 12(2):239-43. PubMed ID: 21359872 [TBL] [Abstract][Full Text] [Related]
32. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Mao D; Che J; Li K; Han S; Yue Q; Zhu L; Zhang W; Li L Arch Gynecol Obstet; 2010 Oct; 282(4):371-5. PubMed ID: 19806356 [TBL] [Abstract][Full Text] [Related]
33. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. Visser M; Vermeulen MA; Richir MC; Teerlink T; Houdijk AP; Kostense PJ; Wisselink W; de Mol BA; van Leeuwen PA; Oudemans-van Straaten HM Br J Nutr; 2012 May; 107(10):1458-65. PubMed ID: 22129964 [TBL] [Abstract][Full Text] [Related]
34. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease. Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ; Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271 [TBL] [Abstract][Full Text] [Related]
35. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870 [TBL] [Abstract][Full Text] [Related]
37. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734 [TBL] [Abstract][Full Text] [Related]
38. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells. Davids M; Teerlink T Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667 [TBL] [Abstract][Full Text] [Related]
39. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients. Coen G; Mantella D; Sardella D; Beraldi MP; Ferrari I; Pierantozzi A; Lippi B; Di Giulio S J Nephrol; 2009; 22(5):616-22. PubMed ID: 19809994 [TBL] [Abstract][Full Text] [Related]
40. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Grasemann H; Al-Saleh S; Scott JA; Shehnaz D; Mehl A; Amin R; Rafii M; Pencharz P; Belik J; Ratjen F Am J Respir Crit Care Med; 2011 May; 183(10):1363-8. PubMed ID: 21278301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]